Form 8-K - Current report:
SEC Accession No. 0001193125-22-262243
Filing Date
2022-10-13
Accepted
2022-10-13 17:04:08
Documents
16
Period of Report
2022-10-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d411205d8k.htm   iXBRL 8-K 31919
2 EX-5.1 d411205dex51.htm EX-5.1 13519
7 GRAPHIC g411205page01.jpg GRAPHIC 4037
8 GRAPHIC g411205page01a.jpg GRAPHIC 1945
  Complete submission text file 0001193125-22-262243.txt   220013

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zyme-20221013.xsd EX-101.SCH 3586
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zyme-20221013_def.xml EX-101.DEF 14289
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20221013_lab.xml EX-101.LAB 23487
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20221013_pre.xml EX-101.PRE 15177
10 EXTRACTED XBRL INSTANCE DOCUMENT d411205d8k_htm.xml XML 5515
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 206-337-1030
Zymeworks Delaware Inc. (Filer) CIK: 0001937653 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41535 | Film No.: 221309587
SIC: 2834 Pharmaceutical Preparations